In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) was $253.14 for the day, down -0.25% from the previous closing price of $253.78. In other words, the price has decreased by -$0.25 from its previous closing price. On the day, 1.01 million shares were traded. ALNY stock price reached its highest trading level at $255.155 during the session, while it also had its lowest trading level at $248.1801.
Ratios:
Our analysis of ALNY’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.38 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 101.92. For the most recent quarter (mrq), Quick Ratio is recorded 2.93 and its Current Ratio is at 3.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on August 16, 2024, Upgraded its rating to Buy and sets its target price to $370 from $198 previously.
On February 16, 2024, Goldman Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $173.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 20 ’24 when Greenstreet Yvonne sold 15,000 shares for $280.00 per share. The transaction valued at 4,200,000 led to the insider holds 73,441 shares of the business.
Greenstreet Yvonne bought 15,000 shares of ALNY for $4,200,000 on Aug 20 ’24. On Aug 12 ’24, another insider, Fitzgerald Kevin Joseph, who serves as the CSO & EVP, Head of Research of the company, sold 22,025 shares for $270.99 each. As a result, the insider received 5,968,516 and left with 12,881 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALNY now has a Market Capitalization of 32574054400 and an Enterprise Value of 32663996416. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.86. Its current Enterprise Value per Revenue stands at 13.933 whereas that against EBITDA is 206.771.
Stock Price History:
Over the past 52 weeks, ALNY has reached a high of $287.55, while it has fallen to a 52-week low of $141.98. The 50-Day Moving Average of the stock is -1.14%, while the 200-Day Moving Average is calculated to be 36.20%.
Shares Statistics:
ALNY traded an average of 1.21M shares per day over the past three months and 1205820 shares per day over the past ten days. A total of 128.38M shares are outstanding, with a floating share count of 127.22M. Insiders hold about 0.90% of the company’s shares, while institutions hold 93.94% stake in the company. Shares short for ALNY as of 1723680000 were 4516039 with a Short Ratio of 3.73, compared to 1721001600 on 4493570. Therefore, it implies a Short% of Shares Outstanding of 4516039 and a Short% of Float of 4.05.
